12 May 2022
ARIX BIOSCIENCE PLC (the "Company")
Publication of Annual Report and Notice of Annual General Meeting
Further to the Company's 2021 Annual Financial Results announcement issued on 5 May 2022, Arix Bioscience Plc, announces that it has today published the Annual Report and Accounts (the "Annual Report") for the financial year ended 31 December 2021 together with its Notice of 2022 Annual General Meeting (the "AGM").
The Company hereby confirms that its Annual General Meeting will be held on Tuesday 7 June 2022 at 11:00 (BST) at the offices of Brown Rudnick LLP, 8 Clifford Street, London, W1S 2LQ, United Kingdom.
The following documents have today been posted or otherwise made available to shareholders by the Company:
1. Form of Proxy
2. Notice of 2022 Annual General Meeting
3. Annual Report and Accounts 2021
The Form of Proxy is publicly available on the Company's website:
https://arixbioscience.com/investor-relations/document-library
The Annual Report and Notice of AGM is also publicly available on the Company's website:
https://arixbioscience.com/investor-relations/document-library
Copies of the above documents have been submitted to the UK National Storage Mechanism. The documents will therefore shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the following address:
Arix Bioscience Plc
Duke Street House,
50 Duke Street,
London,
W1K 6JL,
United Kingdom
Enquiries:
Email: ir@arixbioscience.com
LEI: 213800OVT3AHQCXNIX43
Registrar and Receiving Agent: Equiniti Limited - 0371 384 2030 or +44 121 415 7047
Company Secretary: Kin Company Secretarial Limited - +44 20 8819 6486